A nonsurgical brain implant enabled through a cell-electronics hybrid for focal neuromodulation

Researchers have developed a groundbreaking nonsurgical brain implant technology that combines cell-electronics hybrid systems for targeted neuromodulation. This innovative approach utilizes photovoltaic devices attached to immune cells that can travel through the bloodstream to specific inflamed brain regions, enabling precise therapeutic intervention without invasive surgery. The technology represents a significant advancement in neuroscience and medical device development, offering new possibilities for treating neurological disorders such as epilepsy, Parkinson's disease, and chronic pain. By leveraging the natural homing capabilities of immune cells to sites of inflammation, the implants can reach previously inaccessible brain regions with unprecedented precision. Shubham Yadav, Ray X. Lee, and Deblina Sarkar led the research team that developed this novel approach, which was published in Nature Biotechnology on November 5, 2025. The open-access article details the design, testing, and potential applications of this revolutionary neuromodulation technology.